Mode
Text Size
Log in / Sign up
N/A N=304 Randomized Single-blind Health Services Research

The Bronchiolitis Follow-up Intervention Trial

Bronchiolitis

Enrolled (actual)
304
Serious AEs
0.0%
Results posted
May 2020
Primary outcome: Primary: Parental Anxiety — 4.2; 3.9 points on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Scheduled PCP follow-up (Behavioral); As needed PCP follow-up (Behavioral)
Age
Pediatric
Sex
All
Sponsor
University of Utah
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Parental Anxiety
4.2; 3.9
SECONDARY
Time From Hospital Discharge to Cough Resolution
9.8; 9.2
SECONDARY
Time From Hospital Discharge to Child Reported Back to Normal
9.6; 8.8
SECONDARY
Number of Clinic Visits Prior to Symptom Resolution
1.1; 0.5
SECONDARY
Any Hospital Re-admission Prior to Symptom Resolution
3.8; 2.2
SECONDARY
Any ED Visit Prior to Symptom Resolution
3.8; 5.8
SECONDARY
Number of Missed Work Days
2.1; 1.6
SECONDARY
Missed Daycare
1.2; 0.8
SECONDARY
Ambulatory Prescriptions (Albuterol, Antibiotics, Steroids)
16.0; 9.4
SECONDARY
Ambulatory Testing (i.e. Pulse Oximetry, Chest X-ray)
67; 22
SECONDARY
Relationship With PCP
26.0; 26.5
SECONDARY
Report That Care Was Perfect 1 Month After Discharge
99.2; 97.6
SECONDARY
Immunizations Received 1 Month After Discharge
36.2; 32.8

Summary

This study evaluates the value of routine follow-up with a child's pediatrician after hospitalization for bronchiolitis. Parents of half of participants will be instructed to follow-up with the child's pediatrician regardless of symptom resolution, while the other half will be instructed to follow-up on an as-needed basis (only if the child worsens, doesn't improve, or other concerns develop).

Eligibility Criteria

Inclusion Criteria

  • Children less than two years of age who are hospitalized with an attending physician diagnosis of bronchiolitis.

Exclusion Criteria

  • Chronic lung disease
  • Complex or hemodynamically significant heart disease
  • Immunodeficiency
  • Neuromuscular disease
  • Discharged home with medication for withdrawal
  • Inpatient team believes the child should follow up with their PCP
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03354325). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search